back to top
HomeSHARE MARKET₹14 Share Again In News: Fund Raising Announced; Board Meeting January 22

₹14 Share Again In News: Fund Raising Announced; Board Meeting January 22

Hot Stocks Alert Join

Smallcap business Evoq Remedies is in the spotlight once more. The owner of Evoq Remedies has sold his 72 percent stake in the business for the highest price.

At present, Evoq Remedies has announced to seek out funds. Since the announcement was made there was an enormous increase in the Evoq Remedies shares. 

The company’s shares have increased to the price of 15.18 which is an increase of more than 15. 

Evoq Remedies shares fell by more than 24% within two days following the day that the promoters of the company had to sell their stake.

Board Meeting On 22 January

Evoq Remedies has said in its filing on exchanges that the board meeting of the company is scheduled for January 22, 2024.

At this meeting members of the Board of Directors of the company will review and then approve the idea of raising funds by way of preferential allotment shares. 

The 52-week high for Evoq Remedies shares is Rs 19.44. In the same way, the 52-week low of shares in the company is 10.50.

Promoters Sold 72 Lakh Shares Worth 1 Crore

Promoters for Evoq Remedies have sold the largest part of the business. The promoters have sold their stake for a very high price. 

The company stated in an exchange report on the 10th of January 2024 that they had received an export request of the sum of Rs 136 crore in the form of Marlex Pharmaceuticals of America. 

Following this announcement, the company’s shares increased by 20 percent. The promoters of the company Bhumishtha Narendrabhai &  Payal Patel each sold 11.5 lakh shares on the 10th of January. 

The shares of Evoq Remedies gained on January 11, and the shares of the company reached an all-time high of 52 weeks. 

Promoter Bhumishtha Narendrabhai, and Payal Patel both sold 30.6 lakh & 18.5 lakh shares of their company on 11th January. 

At the end of the period of September 20, 2023, the promoters owned a total of 1 crore shares, of which they traded the equivalent of 72 lakh shares.

About Evoq Remedies Ltd

Evoq Remedies Limited is engaged in the business of pharmaceuticals. They are involved with the trading, marketing, and distribution of different pharmaceutical formulas. 

These include antibiotics, anti-malarial medications such as anti-allergic and anti-cold medications, analgesic/antipyretic and anti-inflammatory medications, dermatology products and cerebral activator medications, neurochemical drugs such as gastrointestinal drugs steroids, gynecology medications such as calcium, multivitamins, anti-oxidants, and injectables. 

The company was formed in the year 2010 with the title SALUS LIFE & Research Private Limited. 

Then it was changed into EVOQ Remedies Private Limited under the Certificate of Registration issued by Registrar of Companies, Ahmedabad in 2019. 

Fundamental Analysis of Evoq Remedies Ltd

Market Cap₹ 19.2 Cr.
Current Price₹ 14.2
52-wk High₹ 19.4
52-wk Low₹ 10.5
Stock P/E14.2
Book Value₹ 18.3
Dividend0.00 %
ROCE6.97 %
ROE6.76 %
Face Value₹ 10.0
P/B Value0.77
OPM-46.7 %
EPS₹ 1.00
Debt₹ 1.28 Cr.
Debt to Equity0.05

Evoq Remedies Share Price Target 2024 To 2030

Year1st Target2nd Target
2024₹ 17₹ 32
2025₹ 34₹ 51
2026₹ 65₹ 85
2027₹ 100₹ 125
2028₹ 160₹ 205
2029₹ 280₹ 450
2030₹ 460₹ 530
Hot Stocks Alert Join

Evoq Remedies Shareholding Pattern

Promoters Holding
Mar 202273.53%
Sept 202273.53%
Mar 202373.53%
Sept 202373.53%
Public Holding
Mar 202226.47%
Sept 202226.48%
Mar 202326.47%
Sept 202326.47%

Evoq Remedies Ltd Share: Last 5 Years’ Financial Condition

To gain a better understanding of how the market is performing, let’s look at the outlook of this share in the previous years. 

However, investors should be aware of the risks and the market conditions before making any investment decision.

Last 5 Years’ Sales:

2019₹ 3.25 Cr
2020₹ 9.07 Cr
2021₹ 10.02 Cr
2022₹ 16.78 Cr
2023₹ 8.50 Cr
Hot Stocks Alert Join

Last 5 Years’ Net Profit:

2019₹ 0.01 Cr
2020₹ 0.00 Cr
2021₹ 0.72 Cr
2022₹ 1.09 Cr
2023₹ 1.36 Cr

Last 5 Years’ Debt-To-Equity Ratio:


Last 10 Years’ Profit Growth:

10 Years:
5 Years:
3 Years:
Current Year:103%
Hot Stocks Alert Join

Last 10 years’ Return on Equity (ROE):

10 Years:
5 Years:
3 Years:9%
Last Year:7%

Sales Growth Over 10 Years:

10 Years:
5 Years:
3 Years:31%
Current Year:-69%


This article is a complete guide about Evoq Remedies Share.

These information and forecasts are based on our analysis, research, company fundamentals and history, experiences, and various technical analyses. 

Also, We have talked in detail about the share’s future prospects and growth potential.

Hopefully, these informations will help you in your further investment. 

If you are new to our website and want to get all the latest updates related to the stock market, join us on Telegram Group.

If you have any further queries, please comment below. We will be happy to answer all your questions. 

If you like this information, share the article with as many people as possible.

Also Read: ₹203 Govt Share: 18 Experts Tracking This Govt Stock; Don’t Sell Before ₹278

Disclaimer: Dear readers, we’d like to inform you that we are not authorized by SEBI (Securities and Exchange Board of India). The information on this site is only for informational and educational purposes and shouldn’t be considered financial advice or stock recommendations. Also, the share price predictions are completely for reference purposes. The price predictions will only be valid when there are positive signs on the market. Any uncertainty about the company’s future or the current state of the market will not be considered in this study. We are not responsible for any financial loss you might incur through the information on this site. We are here to provide timely updates about the stock market and financial products to help you make better investment choices. Do your own research before any investment.




Please enter your comment!
Please enter your name here